Literature DB >> 15806581

Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders.

Nicola J Camp1, Michael R Lowry, R Lynn Richards, Agnes M Plenk, Catherine Carter, Charles H Hensel, Victor Abkevich, Mark H Skolnick, Donna Shattuck, Kerry G Rowe, Dana C Hughes, Lisa A Cannon-Albright.   

Abstract

Major depressive disorder (MDD) is a common, clinically heterogeneous disorder often found comorbid with other disorders. We studied recurrent, early-onset MDD (MDD-RE) and anxiety disorders in combination to define powerful phenotypes for genetic study. We used 87 large, extended Utah pedigrees to investigate linkage to 3 phenotypes: "MDD-RE;" "MDD-RE or anxiety;" and "MDD-RE and anxiety;" where in the latter definition the disorders must appear comorbid within an individual. Pedigrees ranged in size from 2 to 6 generations and contained 3 to 42 individuals affected with MDD or anxiety (718 total). In primary analyses, we identified three regions with at least suggestive genome-wide evidence for linkage on chromosomes 3centr, 7p, and 18q. Both 7p and 18q are replication findings for related phenotypes. The best linkage evidence was for a novel locus at 3p12.3-q12.3 (LOD = 3.88, "MDD-RE or anxiety") and 18q21.33-q22.2 (LOD = 3.75, "MDD-RE and anxiety"), a well-established susceptibility locus for bipolar disorder. In our secondary sex-specific analyses, we identified two further regions of interest on chromosomes 4q and 15q. Using linked pedigrees, we localized 3centr and 18q to 9.8 and 12.2 cM, respectively, with potential for further localization with the addition of markers in specific pedigrees. Our success in replication and novel locus identification illustrates the utility of large extended pedigrees for common disorders, such as MDD. Further, it supports the hypothesis that MDD and anxiety disorders have over-lapping genetic etiologies and suggests that comorbid diagnoses may be useful in defining more genetically homogeneous forms of MDD for linkage mapping. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15806581     DOI: 10.1002/ajmg.b.30177

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  24 in total

1.  Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms.

Authors:  N Amin; O Jovanova; H H H Adams; A Dehghan; M Kavousi; M W Vernooij; R P Peeters; F M S de Vrij; S J van der Lee; J G J van Rooij; E M van Leeuwen; L Chaker; A Demirkan; A Hofman; R W W Brouwer; R Kraaij; K Willems van Dijk; T Hankemeier; W F J van Ijcken; A G Uitterlinden; W J Niessen; O H Franco; S A Kushner; M A Ikram; H Tiemeier; C M van Duijn
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

Review 2.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

3.  Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21.

Authors:  Kristina Allen-Brady; Peggy A Norton; James M Farnham; Craig Teerlink; Lisa A Cannon-Albright
Journal:  Am J Hum Genet       Date:  2009-04-23       Impact factor: 11.025

4.  Meta-analyses of genome-wide linkage scans of anxiety-related phenotypes.

Authors:  Bradley T Webb; An-Yuan Guo; Brion S Maher; Zhongming Zhao; Edwin J van den Oord; Kenneth S Kendler; Brien P Riley; Nathan A Gillespie; Carol A Prescott; Christel M Middeldorp; Gonneke Willemsen; Eco Jc de Geus; Jouke-Jan Hottenga; Dorret I Boomsma; Eline P Slagboom; Naomi R Wray; Grant W Montgomery; Nicholas G Martin; Margie J Wright; Andrew C Heath; Pamela A Madden; Joel Gelernter; James A Knowles; Steven P Hamilton; Myrna M Weissman; Abby J Fyer; Patricia Huezo-Diaz; Peter McGuffin; Anne Farmer; Ian W Craig; Cathryn Lewis; Pak Sham; Raymond R Crowe; Jonathan Flint; John M Hettema
Journal:  Eur J Hum Genet       Date:  2012-04-04       Impact factor: 4.246

5.  PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders.

Authors:  Zhongchun Liu; Fan Zhu; Lihua Yao; Can Yang; Ling Xiao; Junhong Zhu; Huiling Wang; Gaohua Wang; Wanhong Liu; Zheman Xiao
Journal:  Int J Clin Exp Med       Date:  2013-09-01

Review 6.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

7.  Genome-wide linkage scans for major depression in individuals with alcohol dependence.

Authors:  Po-Hsiu Kuo; Michael C Neale; Dermot Walsh; Diana G Patterson; Brien Riley; Carol A Prescott; Kenneth S Kendler
Journal:  J Psychiatr Res       Date:  2010-01-13       Impact factor: 4.791

8.  An exploration of attitudes among black Americans towards psychiatric genetic research.

Authors:  Eleanor Murphy; Azure Thompson
Journal:  Psychiatry       Date:  2009       Impact factor: 2.458

9.  Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource.

Authors:  Craig C Teerlink; Nicola J Camp; Aruna Bansal; Robert Crapo; Dana Hughes; Edward Kort; Kerry Rowe; Lisa A Cannon-Albright
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

10.  Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population.

Authors:  Taro Kishi; Tsuyoshi Kitajima; Masashi Ikeda; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.